|
GTF2H1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.491800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.295200E-01 |
| Normal-vs-Stage2 |
8.009200E-01 |
| Normal-vs-Stage3 |
2.972600E-01 |
| Normal-vs-Stage4 |
7.543000E-01 |
| Stage1-vs-Stage2 |
4.364600E-01 |
| Stage1-vs-Stage3 |
7.349900E-02 |
| Stage1-vs-Stage4 |
4.050600E-01 |
| Stage2-vs-Stage3 |
6.357600E-01 |
| Stage2-vs-Stage4 |
9.845400E-01 |
| Stage3-vs-Stage4 |
6.155400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.439200E-01 |
| Normal-vs-AfricanAmerican |
9.578000E-02 |
| Normal-vs-Asian |
1.482640E-01 |
| Caucasian-vs-AfricanAmerican |
8.181700E-02 |
| Caucasian-vs-Asian |
1.450840E-01 |
| AfricanAmerican-vs-Asian |
9.001800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.565600E-01 |
| Normal-vs-Female |
7.109000E-01 |
| Male-vs-Female |
4.959000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.043600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.775400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.686000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.261400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.639980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.096400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.578800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.450500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.134210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.699200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.042790E-01 |
| Normal-vs-Grade 2 |
2.482600E-01 |
| Normal-vs-Grade 3 |
4.021400E-01 |
| Normal-vs-Grade 4 |
2.911600E-01 |
| Grade 1-vs-Grade 2 |
2.860600E-01 |
| Grade 1-vs-Grade 3 |
5.755700E-02 |
| Grade 1-vs-Grade 4 |
1.107570E-01 |
| Grade 2-vs-Grade 3 |
4.402000E-02 |
| Grade 2-vs-Grade 4 |
8.468400E-02 |
| Grade 3-vs-Grade 4 |
5.600800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.275860E-02 |
| Normal-vs-ccB subtype |
8.187800E-02 |
| ccA subtype-vs-ccB subtype |
4.49660000000351E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.655400E-01 |
| Normal-vs-N1 |
9.909800E-01 |
| N0-vs-N1 |
9.996600E-01 |
|
|
